Literature DB >> 27026733

Sudden-Onset Sensorineural Hearing Loss after Immunization: A Case-Centered Analysis.

Roger Baxter1, Ned Lewis2, Pamela Bohrer3, Theresa Harrington4, Laurie Aukes2, Nicola P Klein2.   

Abstract

OBJECTIVE: Case reports of sudden sensorineural hearing loss (SSHL) following vaccines have led to concerns that vaccines may rarely cause hearing loss. Because of this concern, we analyzed for an association between SSHL and vaccinations. STUDY
DESIGN: We used a case-centered method, equivalent to a case control design using immunization dates from all matched members of the population to calculate exposure to vaccines, rather than sampling.
SETTING: Kaiser Permanente Northern California (KPNC), 2007 to 2013. SUBJECTS AND METHODS: We searched KPNC databases from 2007 to 2013 for all first-time diagnoses of SSHL. We used the date of any hearing- or ear-related visit in the 60 days prior to the first SSHL diagnosis as the onset date. Using only SSHL cases immunized in the prior 9 months, we compared the vaccine exposure in several risk intervals prior to onset with the exposure to the same vaccine during the same time period in all KPNC membership, matched to sex and age.
RESULTS: During the study period, >20 million vaccines were administered at KPNC. In all risk intervals prior to onset of SSHL, we found no evidence of increased risk of immunization compared with matched controls. The odds ratios for vaccination 1 week prior to SSHL were 0.965 (95% confidence interval, 0.61-1.50) for trivalent inactivated influenza vaccine (TIV); 0.842 (0.39-1.62) for tetanus, reduced diphtheria, and reduced acellular pertussis; and 0.454 (0.08-1.53) for zoster vaccine.
CONCLUSION: A large-scale analysis applying a case-centered method did not detect any association between SSHL and previous receipt of TIV or other vaccines. © American Academy of Otolaryngology—Head and Neck Surgery Foundation 2016.

Entities:  

Keywords:  adverse event; hearing loss; immunization; influenza vaccine; sensorineural; vaccine

Mesh:

Substances:

Year:  2016        PMID: 27026733      PMCID: PMC6708600          DOI: 10.1177/0194599816639043

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  7 in total

1.  Acute Demyelinating Events Following Vaccines: A Case-Centered Analysis.

Authors:  Roger Baxter; Edwin Lewis; Kristin Goddard; Bruce Fireman; Nandini Bakshi; Frank DeStefano; Julianne Gee; Hung Fu Tseng; Allison L Naleway; Nicola P Klein
Journal:  Clin Infect Dis       Date:  2016-09-01       Impact factor: 9.079

Review 2.  Safety of Human Papillomavirus Vaccines: An Updated Review.

Authors:  Anastasia Phillips; Cyra Patel; Alexis Pillsbury; Julia Brotherton; Kristine Macartney
Journal:  Drug Saf       Date:  2018-04       Impact factor: 5.606

3.  Assessment of Sudden Sensorineural Hearing Loss After COVID-19 Vaccination.

Authors:  Eric J Formeister; Matthew J Wu; Divya A Chari; Robert Meek; Steven D Rauch; Aaron K Remenschneider; Alicia M Quesnel; Ronald de Venecia; Daniel J Lee; Wade Chien; C Matthew Stewart; Deepa Galaiya; Elliott D Kozin; Daniel Q Sun
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2022-04-01       Impact factor: 8.961

4.  Post Vaccinal Temporary Sensorineural Hearing Loss.

Authors:  Federica De Marco; Donato Pompeo De Cesare; Francesco Di Folco; Francesco Massoni; Gianfranco Tomei; Natale Mario Di Luca; Carmina Sacco; Francesco Tomei; Ricci Serafino
Journal:  Int J Environ Res Public Health       Date:  2018-08-19       Impact factor: 3.390

5.  Association between human papillomavirus infection and sudden sensorineural hearing loss: A nationwide population-based cohort study.

Authors:  Thomas Yen-Ting Chen; Renin Chang; Yao-Min Hung; Hei-Tung Yip; James Cheng-Chung Wei
Journal:  EClinicalMedicine       Date:  2022-04-21

6.  Hearing disorder following COVID-19 vaccination: A pharmacovigilance analysis using the Vaccine Adverse Event Reporting System.

Authors:  Congqin Chen; Fang Fu; Lingqing Ding; Jie Xiao
Journal:  J Clin Pharm Ther       Date:  2022-09-11       Impact factor: 2.145

7.  Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.

Authors:  Sarah Schillie; Claudia Vellozzi; Arthur Reingold; Aaron Harris; Penina Haber; John W Ward; Noele P Nelson
Journal:  MMWR Recomm Rep       Date:  2018-01-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.